线粒体功能障碍和心血管疾病的当前进展以及有前途的治疗策略
Dexiang Xia1, Yue Liu1, Peng Wu2
1Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical School, University of South China, Hengyang, China.
The American journal of pathology
|July 22, 2023
概括
线粒体功能障碍是心血管疾病的核心,如心力衰竭和动脉样硬化. 本综述探讨了针对线粒体的治疗策略,以对抗这些疾病.
科学领域:
- 细胞生物学 细胞生物学
- 心血管医学 心血管医学
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体对于细胞能量和恒常状态至关重要.
- 线粒体功能障碍越来越多地与心血管疾病的发病有关.
- 关键的心血管疾病包括线粒体功能障碍.
研究的目的:
- 审查线粒体功能障碍在心血管疾病中的作用.
- 讨论心血管疾病的线粒体向疗法的进展.
- 评估这些策略的临床潜力和挑战.
主要方法:
- 科学文章的文学评论. 科学文章的文献评论.
- 对心血管疾病中的线粒体功能障碍研究的分析.
- 检查针对线粒体的治疗方法.
主要成果:
- 线粒体功能障碍有助于动脉样硬化,心力衰竭,缺血-再输血损伤和肺动脉高血压.
- 针对线粒体的抗氧化剂,质量控制调节剂和功能保护剂显示出有前途.
- 线粒体生物发生促进剂和移植代表了新兴的治疗途径.
结论:
- 了解线粒体功能障碍对于心血管疾病治疗至关重要.
- 针对线粒体提供了一个有希望的治疗前沿.
- 基于线粒体的策略的临床翻译需要进一步的研究和开发.
更多相关视频
相关概念视频
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Mitochondrial Membranes
11.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.6K
Mitochondria
13.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.9K
Cardiomyopathy V: Interprofessional Care
17
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure V: Medical Management
14
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
14


